Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab

M.J. Bishton, Michael Leahy, R.J. Hicks, J Turner, A.D. Mcquillan, J.F. Seymour

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab'. Together they form a unique fingerprint.

    Medicine & Life Sciences